Vimarsana
Biggest News Aggregation in the World

Page 20 - Antitrust Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antitrust Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antitrust Division Today - Breaking & Trending Today

Healthcare Organizations are Facing Increased Scrutiny – Here's What You Need to Know | NAVEX - Vimarsana News

Healthcare Organizations are Facing Increased Scrutiny – Here's What You Need to Know | NAVEX

2024 is shaping up to be a very active year for regulatory and enforcement developments in the healthcare industry – developments that concern not just hospitals and nursing facilities,...

Employers Beware: Worker Misclassification May Be Seen as Anticompetitive Conduct | Troutman Pepper - Vimarsana News

Employers Beware: Worker Misclassification May Be Seen as Anticompetitive Conduct | Troutman Pepper

Speaking at the Global Competition Review: Law Leaders Global Summit last month, Commissioner Alvaro M. Bedoya of the Federal Trade Commission (FTC) argued that the FTC could — and...

DOJ, State And DC AGs: Apple's Conduct In Smartphone Market Violates Antitrust Laws - Antitrust, EU Competition - Vimarsana News

DOJ, State And DC AGs: Apple's Conduct In Smartphone Market Violates Antitrust Laws - Antitrust, EU Competition

Apple Inc. has used its dominant position, restrictive contracts, and even delay new product features, combined with a strategy of getting people "locked in" and "hooked on the ecosystem," to monopolize the smartphone market.

Source: mondaq.com
Mira Pharmaceuticals Steps Closer To Ketamir-2 IND Submission After Positive Preclinical Results - Vimarsana News

Mira Pharmaceuticals Steps Closer To Ketamir-2 IND Submission After Positive Preclinical Results

Pharmaceutical company MIRA Pharmaceuticals, Inc. (MIRA) said Tuesday it is conducting pre-clinical studies of Ketamir-2 in collaboration with Frontage Laboratories as a potential treatment for individuals battling treatment-resistant depression (TRD), major depressive disorder with suicidal ideation (MDSI) and post-traumatic stress disorder (PTSD).

Paychex Q3 Net Income Rises; Updates FY24 Guidance - Vimarsana News

Paychex Q3 Net Income Rises; Updates FY24 Guidance

Paychex, Inc. (PAYX) reported that its third quarter net income increased to $498.6 million from $467.4 million, last year. Earnings per share was $1.38 compared to $1.